<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.3.1" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
<channel>
	<title>Comments on: When There Is Blood In The Streets - Buy Biotech</title>
	<link>http://www.hammerstockblog.com/when-there-is-blood-in-the-streets-buy-biotech/</link>
	<description>Biotech stock reviews</description>
	<pubDate>Sun, 14 Mar 2010 02:13:31 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.3.1</generator>
		<item>
		<title>By: Jolly Rancher</title>
		<link>http://www.hammerstockblog.com/when-there-is-blood-in-the-streets-buy-biotech/#comment-1285</link>
		<dc:creator>Jolly Rancher</dc:creator>
		<pubDate>Fri, 11 Dec 2009 20:15:47 +0000</pubDate>
		<guid>http://www.hammerstockblog.com/when-there-is-blood-in-the-streets-buy-biotech/#comment-1285</guid>
		<description>Thanks. Many trials will complete within the next 3 months. I purchased today.</description>
		<content:encoded><![CDATA[<p>Thanks. Many trials will complete within the next 3 months. I purchased today.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ohad Hammer</title>
		<link>http://www.hammerstockblog.com/when-there-is-blood-in-the-streets-buy-biotech/#comment-1284</link>
		<dc:creator>Ohad Hammer</dc:creator>
		<pubDate>Fri, 11 Dec 2009 16:50:10 +0000</pubDate>
		<guid>http://www.hammerstockblog.com/when-there-is-blood-in-the-streets-buy-biotech/#comment-1284</guid>
		<description>Hi Jolly,
Yes I still consider ARRY as a buy but I have to say I am a little bit worried by the lack of partnership deals that should have brought fresh funds to the company.
Their MEK inhibitor should get a good price as well as the diabetese drug, but they are walking a tight rope. Other than that, they have one of the best discovery engines in the industry

ohad</description>
		<content:encoded><![CDATA[<p>Hi Jolly,<br />
Yes I still consider ARRY as a buy but I have to say I am a little bit worried by the lack of partnership deals that should have brought fresh funds to the company.<br />
Their MEK inhibitor should get a good price as well as the diabetese drug, but they are walking a tight rope. Other than that, they have one of the best discovery engines in the industry</p>
<p>ohad</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jolly Rancher</title>
		<link>http://www.hammerstockblog.com/when-there-is-blood-in-the-streets-buy-biotech/#comment-1281</link>
		<dc:creator>Jolly Rancher</dc:creator>
		<pubDate>Thu, 10 Dec 2009 16:21:40 +0000</pubDate>
		<guid>http://www.hammerstockblog.com/when-there-is-blood-in-the-streets-buy-biotech/#comment-1281</guid>
		<description>Ohad,

I think the title of this article is very appropriate to keep in mind when buying biotech stocks. Recently ARQL share price was in the dumpster. I bought at $3.24; so I have a nice basis. Thanks for your recommendation. Recently another one of your stocks is in the dumpster, ARRY, and you have recently stated that you still like it. They have good partnerships, good technology, and good management. Would you consider ARRY a dumpster "blood in the streets" buy at $1.98? I'm thinking about picking up a few shares.

Thanks,
JR</description>
		<content:encoded><![CDATA[<p>Ohad,</p>
<p>I think the title of this article is very appropriate to keep in mind when buying biotech stocks. Recently ARQL share price was in the dumpster. I bought at $3.24; so I have a nice basis. Thanks for your recommendation. Recently another one of your stocks is in the dumpster, ARRY, and you have recently stated that you still like it. They have good partnerships, good technology, and good management. Would you consider ARRY a dumpster &#8220;blood in the streets&#8221; buy at $1.98? I&#8217;m thinking about picking up a few shares.</p>
<p>Thanks,<br />
JR</p>
]]></content:encoded>
	</item>
</channel>
</rss>
